Thomas Gould
Question:206. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 1.1.1 of the national drugs strategy plan upon completion of the 2020 review. [25954/21]
View answerDáil Éireann Debate, Wednesday - 23 June 2021
206. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 1.1.1 of the national drugs strategy plan upon completion of the 2020 review. [25954/21]
View answer207. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 1.1.2 of the national drugs strategy plan upon completion of the 2020 review. [25955/21]
View answer208. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 1.2.3 of the national drugs strategy plan upon completion of the 2020 review. [25956/21]
View answer209. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 1.2.4 of the National Drugs Strategy upon completion of the 2020 review. [25957/21]
View answer210. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 1.2.5 of the national drugs strategy plan upon completion of the 2020 review. [25958/21]
View answer211. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 1.2.6 of the national drugs strategy plan upon completion of the 2020 review. [25959/21]
View answer212. Deputy Thomas Gould asked the Minister for Health the actions that actions have been taken under Action 1.2.7 of the national drugs strategy plan upon completion of the 2020 review. [25960/21]
View answer213. Deputy Thomas Gould asked the Minister for Health the actions that actions have been taken under Action 1.2.8 of the national drugs strategy plan upon completion of the 2020 review. [25961/21]
View answer214. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 1.3.9 of the national drugs strategy plan upon completion of the 2020 review. [25962/21]
View answer215. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 1.3.10 of the national drugs strategy plan upon completion of the 2020 review. [25963/21]
View answer216. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 1.3.11 of the national drugs strategy plan upon completion of the 2020 review. [25964/21]
View answer217. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 2.1.12 of the national drugs strategy plan upon completion of the 2020 review. [25965/21]
View answer218. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 2.1.13 of the national drugs strategy plan upon completion of the 2020 review. [25966/21]
View answer219. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 2.1.14 of the national drugs strategy plan upon completion of the 2020 review. [25967/21]
View answer220. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 2.1.15 of the national drugs strategy plan upon completion of the 2020 review. [25968/21]
View answer221. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 2.1.16 of the national drugs strategy plan upon completion of the 2020 review. [25969/21]
View answer222. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 2.1.17 of the national drugs strategy plan upon completion of the 2020 review. [25970/21]
View answer223. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 2.1.18 of the national drugs strategy plan upon completion of the 2020 review. [25971/21]
View answer224. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 2.1.19 of the national drugs strategy plan upon completion of the 2020 review. [25972/21]
View answer225. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 2.1.20 of the national drugs strategy plan upon completion of the 2020 review. [25973/21]
View answer226. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 2.1.21 of the national drugs strategy plan upon completion of the 2020 review. [25974/21]
View answer227. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 2.1.22 of the national drugs strategy plan upon completion of the 2020 review. [25975/21]
View answer228. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 2.1.23 of the national drugs strategy plan upon completion of the 2020 review. [25976/21]
View answer229. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 2.1.24 of the national drugs strategy plan upon completion of the 2020 review. [25977/21]
View answer230. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 2.1.25 of the national drugs strategy plan upon completion of the 2020 review. [25978/21]
View answer231. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 2.1.26 of the national drugs strategy plan upon completion of the 2020 review. [25979/21]
View answer232. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 2.1.27 of the national drugs strategy plan upon completion of the 2020 review. [25980/21]
View answer233. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 2.2.28 of the national drugs strategy plan upon completion of the 2020 review. [25981/21]
View answer234. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 2.2.29 of the national drugs strategy plan upon completion of the 2020 review. [25982/21]
View answer235. Deputy Thomas Gould asked the Minister for Health the actions that have been undertaken under Action 2.2.30 of the national drugs strategy plan upon completion of the 2020 review. [25983/21]
View answer236. Deputy Thomas Gould asked the Minister for Health the actions that have been undertaken under Action 3.1.31 of the national drugs strategy plan upon completion of the 2020 review. [25984/21]
View answer237. Deputy Thomas Gould asked the Minister for Health the actions that have been undertaken under Action 3.1.32 of the national drugs strategy plan upon completion of the 2020 review. [25985/21]
View answer238. Deputy Thomas Gould asked the Minister for Health the actions that have been undertaken under Action 3.1.33 of the national drugs strategy plan upon completion of the 2020 review. [25986/21]
View answer239. Deputy Thomas Gould asked the Minister for Health the actions that have been undertaken under Action 3.1.34 of the national drugs strategy plan upon completion of the 2020 review. [25987/21]
View answer240. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 3.1.35 of the national drugs strategy plan upon completion of the 2020 review. [25988/21]
View answer241. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 3.2.36 of the national drugs strategy plan upon completion of the 2020 review. [25989/21]
View answer242. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 3.2.37 of the national drugs strategy plan upon completion of the 2020 review. [25990/21]
View answer243. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 3.3.38 of the national drugs strategy plan upon completion of the 2020 review. [25991/21]
View answer244. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 4.1.39 of the national drugs strategy plan upon completion of the 2020 review. [25992/21]
View answer245. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 4.1.40 of the national drugs strategy plan upon completion of the 2020 review. [25993/21]
View answer246. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 4.1.41 of the national drugs strategy plan upon completion of the 2020 review. [25994/21]
View answer247. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 4.1.42 of the national drugs strategy plan upon completion of the 2020 review. [25995/21]
View answer248. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 4.2.43 of the national drugs strategy plan upon completion of the 2020 review. [25996/21]
View answer249. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 4.2.44 of the national drugs strategy plan upon completion of the 2020 review. [25997/21]
View answer250. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 5.1.45 of the national drugs strategy plan upon completion of the 2020 review. [25998/21]
View answer251. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 5.1.46 of the national drugs strategy plan upon completion of the 2020 review. [25999/21]
View answer252. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 5.1.47 of the national drugs strategy plan upon completion of the 2020 review. [26000/21]
View answer253. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 5.1.48 of the national drugs strategy plan upon completion of the 2020 review. [26001/21]
View answer254. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 5.1.49 of the national drugs strategy plan upon completion of the 2020 review. [26002/21]
View answer255. Deputy Thomas Gould asked the Minister for Health the actions that have been taken under Action 6.1.50 of the national drugs strategy plan upon completion of the 2020 review. [26003/21]
View answerI propose to take Questions Nos. 206 to 255, inclusive, together.
The national drug strategy, Reducing Harm, Supporting Recovery, sets out government policy on drug and alcohol use for the period 2017 to 2025. The strategy provides an integrated public health approach to drug and alcohol use, focused on reducing the harms for individuals, families and communities and promoting rehabilitation and recovery. The strategy is a dynamic strategy and contains 50 actions which are to be delivered over the period 2017-2020.
Progress reports are prepared on the activity carried out under the 50 actions contained in the action plan. The 2020 progress report is being finalised and will be released shortly. Progress and Planned Activity reports for the periods 2018 and 2019 are available.
The Deputy will be aware that the Department has commenced a mid-term review of the actions in the strategy, in consultation with stakeholders. The review provides an opportunity to reflect on progress in implementing the strategy to date, progress achieved under the action plan 20217-2020, to identify any new issues that have arisen including the impact of Covid-19 and to consider the development of new actions to address emerging needs and challenges.
The National Oversight Committee gives leadership and direction to support the strategy. The committee has membership from statutory, voluntary and community sector and is chaired by me as Minister for State. The committee has received regular updates on the mid-term review and a draft report was presented to a special meeting of the committee on 18 June for its consideration.
The review when finalised will be brought to Government for approval. Publication of the review will follow soon thereafter. This will include progress on all the actions in the Strategy, including those referenced by the Deputy.
I am committed to working with all stakeholders to ensure that the national drugs strategy is relevant and appropriate to address the societal challenges arising from the use of drugs, especially for children and young people and for those at greatest risk of harm.